120 related articles for article (PubMed ID: 24744344)
1. A workplace colorectal cancer screening program in firefighters: lessons learned.
Walsh JM; Potter MB; Arora M; Gildegorin G; Terdiman J
Occup Med (Lond); 2014 Jun; 64(4):255-8. PubMed ID: 24744344
[TBL] [Abstract][Full Text] [Related]
2. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study.
Gordon NP; Green BB
BMC Public Health; 2015 Jun; 15():546. PubMed ID: 26062732
[TBL] [Abstract][Full Text] [Related]
6. A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.
Denters MJ; Deutekom M; Bossuyt PM; Fockens P; Dekker E
Eur J Cancer Prev; 2013 Jul; 22(4):299-304. PubMed ID: 23169243
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening among Mexican Americans at a community clinic.
Yepes-Rios M; Reimann JO; Talavera AC; Ruiz de Esparza A; Talavera GA
Am J Prev Med; 2006 Mar; 30(3):204-10. PubMed ID: 16476635
[TBL] [Abstract][Full Text] [Related]
8. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
[TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
[TBL] [Abstract][Full Text] [Related]
11. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening in Canada: results of a national survey.
Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
[TBL] [Abstract][Full Text] [Related]
13. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.
Massat NJ; Moss SM; Halloran SP; Duffy SW
J Med Screen; 2013; 20(3):125-48. PubMed ID: 24197771
[TBL] [Abstract][Full Text] [Related]
14. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
[TBL] [Abstract][Full Text] [Related]
15. Evidence for colorectal cancer screening.
Bretthauer M
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
[TBL] [Abstract][Full Text] [Related]
16. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
Seeff LC; Shapiro JA; Nadel MR
J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
[TBL] [Abstract][Full Text] [Related]
17. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
[TBL] [Abstract][Full Text] [Related]
18. Mailed fecal immunochemical tests plus educational materials to improve colon cancer screening rates in Iowa Research Network (IRENE) practices.
Levy BT; Daly JM; Xu Y; Ely JW
J Am Board Fam Med; 2012; 25(1):73-82. PubMed ID: 22218627
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
20. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
